Autologous bone marrow transplantation involves the use of the patient's own marrow to restore haematopoietic function. The reinfused haemopoietic stem cells may be from the:
The main advantages of autologous transplantation is that it may be used in older patients - up to 60-70 years of age - and there is no risk of graft versus host disease. It is also useful when a closely matched allogeneic donor cannot be found and in the treatment of widespread myeloma in young fit patients.
The harvested bone marrow is stored in liquid nitrogen. The patient then undergoes intensive chemo and/or radiotherapy before the marrow is re-infused.
The marrow may be treated in vitro with monoclonal antibodies to remove malignant cells prior to re-infusion.
The main complications are:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.